281 related articles for article (PubMed ID: 14976357)
1. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha.
Kane CD; Francone OL; Stevens KA
Gene; 2006 Oct; 380(2):84-94. PubMed ID: 16828988
[TBL] [Abstract][Full Text] [Related]
3. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
4. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
6. Genomic structure and regulation of the rat hepatic CYP4F1 gene by peroxisome proliferators.
Donelson E; Chen L; Zhang X; Goswami P; Song BJ; Hardwick JP
Arch Biochem Biophys; 2008 Apr; 472(1):1-16. PubMed ID: 18262487
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
9. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
10. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
Varanasi U; Chu R; Huang Q; Castellon R; Yeldandi AV; Reddy JK
J Biol Chem; 1996 Jan; 271(4):2147-55. PubMed ID: 8567672
[TBL] [Abstract][Full Text] [Related]
11. Using laser scanning cytometry to measure PPAR-mediated peroxisome proliferation and beta oxidation.
Pruimboom-Brees IM; Brees DJ; Shen AC; Keener M; Francone O; Amacher DE; Loy JK; Kerlin RL
Toxicol Pathol; 2005; 33(1):86-91. PubMed ID: 15805059
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
Richert L; Price S; Chesne C; Maita K; Carmichael N
Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
[TBL] [Abstract][Full Text] [Related]
14. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
Weglarz TC; Sandgren EP
Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
[TBL] [Abstract][Full Text] [Related]
15. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
16. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
19. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
Nagasawa M; Hara T; Kashino A; Akasaka Y; Ide T; Murakami K
Biochem Pharmacol; 2009 Sep; 78(5):523-30. PubMed ID: 19433068
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
